SIGNAI.UNC moleculcs are [hought to playa signi6cant role in lIetcrmining thc fate or neural erest progenito r cells. Thc human sympathetic chain was identined at 6.5, 7.5,8.2, 10.2 and t 1.4 postconccption (Pe) wecks dcmonstrating low af6nity nerve growth factor (NGF) rtceptors, and was proccssed for liuue culture.ln thc prescnee of epidermal growth factot (EGF), floating sphercs or prolifcrating rrogcnitor eells wen dc:vdoped in vitro. In thc: absence: 0 EGF progenitor cdls diffc:rc:n tiated ioto t yrosine: hyd roxylasc: (TH)-immunorc:activc: neu ronal and TH-nc:gativc: fial cells. NGF [rUlment signi6cantly incrcasc:d neurite outgrowth and surviv.al of TH-immunorcactivc cdls. Thc multipolent eells wc isolatcd differ from prniously rcporte<! sympathoadrenal progeniton in that they give rise to TH immunoreactive neurones precociously sensitive to NGF.
Introduction
Sympathoadrenal (SA) lineage is a neural <:rest derivative that has been investigated in detail.' It differentiates to form sympathetie neurones, the adrenal gland primordia (then ch romafhn cells) and the small intensely flu orescent (SIF) cells. A peeuliar feature of these cell types is their ability to be phenotypically interconverted by speeific environmental signals.
l The plasticity is supposed to reflect the development from a common embryonic progenitor celP-s NGF, along with glucosteroids, is one of the most important environmental determinants of the cell fate in vivo ....... ' Recently, investigators were able to establish a v-mycimmortalized SA progenitor eell line 9 and isolate a common stemcell for neu rones and glia from the mammalian neural erest.'~ Thc purpose of the prcscnt study was to obrai n EGF-responsive progenitor cells from the human developing sympathetic autonomie chain, according to the experimental procedure described for the murine central nervous system by Reynolds and Weiss." Specihe features such as TH expression and early NGF response with neu rite outgrowth and increased survival, were used as speeihc functional assays for the 
Material and Methods
Human embryonic tissues were obtained from patients undergoing therapeutie abortions according to the current Ital ian laws. T he Institutional Ethical Commiuee approved the experiments and informed eonsent from the patients was obtained.
Staging o[ human embryos: Thc age of thc embryos was determined by preoperative ultrasound scanning, wh ich allowed a good estimation of embryonic erownrump length (CRL) and staging bcfore the embryo was obtained by suction abortion. Other distinguished features, such as foot length, hand morphology, last menstrual period (LMP) and staging of developmem accord ing to the Carnegie Collection eriteria'l were rccorded for embryos you nger than PC week 8. For PC age > 8 weeks, donors were staged by LMP and CRL as determined uhrasonically in utero.'· Sonograph ie measurements were able tO predict the gestational age from 8.0 to 12.6 wecks with an accuracy of ::!: 4 days . ' equipped with an epi-fl uorescence condenser.
ECF-dependent progenitor cell isolation in vitro:
To obtain SA cells, specimens at PC weck 6.5, 7.5, 8.2,10.2 and 1104 were collected in sterile Hank's balanced sah solution, pH 7.4 (Gibco) and immed iatcly processed for tissue euhure. The SA system was isolated using 01. sterile technique, under an inverted microseope. After careful dissection of the nervous tissue from meninges, vessels and any other contaminants, sympathetie ganglia were isolated and immed iately cut into picces using seissors. Tissues were then added with Dulbecco's modified Eagle's medium and F I2 nutricnt (1:1, viv; Sigma) supplemented with antibioties and glucose (5 mg I-I). A defined hormone and sah mixture (defined supplements) that ineluded insu lin (25 J.l.g mi-I), transferrin (100 JLg mi-I) progesterone (20 nM), putresci ne (60 JoLM), and sclenium chloride (30 nM) was used in place of serum. T rypsin (11 , Sigma) at a low coneentration (0.08%, v/v) was used to facibtate cell dissociation. T issues were incubated for 15-20 min at 36SC in 5.5% CO/, before trypsin was removed. Dispersed eells were centrifuged (500 x g for 10 min) far pellets and resuspended in DMEM/FI2 and gendydissoeiated by trituration with Pasteur pipenes of progressively smaller bore size. Disperscd cells were thcn plated without any attaehment faeto r. An average viable cell number of 4 x 10' was obtained from a single ganglion. Ten thousand eells were plated in a 16 mm dish in DMEM/F I2 medium with defined supplements and 20 ng ml-1 human recombinant epidermal growth faetor (EGF, Boehringer Mannhei m, IN) in thc absence of serum. After 8-10 days in vltro, lloatingeell clusters (spheres) were collccted, centrifugcd at 500)( g for 10 min, resuspended in EGF-frec medium and then meehanically dissociated to single cells. Isolated EGFdependent progenitor eells were subcu hured in the presencc of EGF-DMEM/F I2 with defined supplements tO obtain second passage spheres (repeatcd passagcs). Spheres were subsequently dissociated to singlecclls and plated at adonaldensityof 100 ~ 6cells on 35 mm Falcon dishes, pre-coated ovcrnight with poly -L-Iysi ne (mol wt 90000-120000, 10 JoLg mi-I in 0.15 M sodium borate buffer, pH 804). Cuhures were ineubated at 36.5°C in a humidified atmosphcre of 5.5% CO/. Every 2-3 days half of the medium was removed from cach weil :tnd replaeed with an equal volume of fes h medium (DMEM/FI2) with defined supplements, in the absence of EGF.
NGF treatment o{ the progenitor cells and morphological e'f.Ialuation: 75 NGF (30 ng ml-' final eoncentr:ttion, Sigma) was added to the eultures on the fi rst in vltro day, 2 h after plati ng. Cells were observed every 4-6 h using an inverted microseope for the first 24 h. Cel l counting was performed after 6 and 12 days in vitra using an inverted microseope with phase contrast objectives and a high numerical opening, magnification )( 320. Selected areasof each weil (approxi mately 7% of the 35 mm weil surface) were seanned for the presencc of ph:tse-bright cells with/without neurites at 6 and 12 days in vitro to determinc both survival rates (number of neurones which h:tve survived in the preseneel absence of NGF) and the percentage of neu rones with neurites (proecsses more th:tn a eel l diameter in length). Approximately 500 viable EGF-dependent progenitor eells (clonal lines) were monitored between 0 and 12 days in vitro both in NGF-treated and control cu ltures.
Immunocytochemisl ry of progenilor ceUs in culture:
Progenitorcells were fixed with 4% paraformaldehyde for 1 hand permeabilizcd with 0.1 % Triton X-IOD for 30 min. After adding goat serum, cuhures were ineubated with an anti-TH monoelonal or polyclonal antibody (monoclonal from Inestar and polyelonal from Eugene Tech, 1: 100 and 1:500 dilution, respectivcly) and, subsequcntly, with goat FITC eonjugated antimouse IgG (1:100) (bioYeda). Progenitor cells were fixed both after 0 days in vitro, immediatel y after attachment (2-3 h), and at 6 days in vitro.
Results
From PC weck 6.5 tO 11 .3 p')..NGI-1I immunoreactivity was localizcd in the ganglia of the sy mpathetic autonomie ehai n symmetrieally positioned in front of the vertebrae. Three anatomiea! regions were analysed (eervical, dorsal and lumbar spinal cord) :tnd p')..:-IGH was found in 01.11 of them in eorrespondenee to the primitive sympathetic chain. Anatomical land marks such as vertebral bod ies were used for disseeti ng sympathetic gangl ia (Fig. 1) . p')..:-IGIIl expression was also found in thc dorsal root ganglia and in the grey matter of the ventral spinal cord (data not shown). Dissociated sympathetic cells were obtained from pe weeks 6.5 to 11.4. In the presence of DMEM/ FI2 with defined sup~ plements and EGF, floating spheres of proliferating cells were easily identified by contrast microscopy after 8-10 days in vitro, regardless of gestational age (Fig. 2) . Second passage spheres were used for cell dispersion. Dissociated EGF-dependent progenitor cells were plated in the presence of an attachment bctor, polY-L-lysine. One hour after plating, progenitor cells were attached to the substrate. TH immunoreactivity was present soon after auachment (1-2 h; Fig. 3 ). Approximatcly 500 viable progenitor cells (clonal lines) were monitored in bOlh NGF-lreated and untreated control cultures. At 1 day in vitra, all viable cells (phase-bright, regular membrane, no granular dcposits) were classified in two different cell types: l1at, no n-neuronal protoplasmic cells and cells with Cl phase-bright cell body and neuronal-like processes (Fig. 'A, B) .
In all the progenitor clones, TH immunoreactivity was present in all of the sympathetic phase-bright neuronal-like cells. No TH immunoreactivity was fig. 6A, B) .
Discussion
This study demonstrates that it is possible to isolate, after a few days in vitra, an EGF-dependent sym pa-
.p thetic progenitor cell from human embryos, which can potentially differentiate into at least twO different cell phenotypes in the presence of attachment factor(s). T he neuronal-li ke cd ls we obtained from the EGFdependent progenitor cell were already eommitted (early immunoreactivity for TH) and promptly responded 10 NGF invitro with hoth neurite extension and inereased survival. At the gestational age we considered, the SA system alrcady migrated to thc adrenal gland, originating ehromaffin eellsY On the other hand. the EGFdependent progenitor cell does not represent a late stage in neural erest eeH differentiation because it retains the ability to generate other neural crest deri vatives such as non-neuronal cells.'o H owcver, its behaviour is different from that already reported for SA progenitors both from embryonic adrenal glands that were initially unresponsive to NGF/ and from thc SA progenitor cell line MAH (v-myc-infected. ad renal derived-HNK-J-positive cells) that failed to respond to NGF.' Different molecu les, including basic fibrob lasl growth factor (FGF). interleukin-6, IGF-l and VIP, have been reported to induce initial neuronal differentiation of SA progenilors.'a-10 Furthermore, FGF and neurotrophin-J were recently reported toinduce NGF responsiveness of SA progenitors aftcr induction of the p"Otrk receptor exprcssion.~'·.!l O ur resuhs SUggC5t that preueatment with EGF may be one of the factors responsible for the induction of early NGF sensitivity in human sympathetic progenitors, after quantitative modulation of signaluansduction through growth factor receptors.
The repertoire of neurotransmitter fates available to the EGF-dependent SA progenitor cell seems to be restricted to the catecholaminergic type, unlike that reported for other SA progenitors such as MAH cells, that have serotonergie as weil as cholinergie and catecholaminergic potentials.'oll Dopamine-ß-hydroxylase (DBH) was demonstrated 10 the THimmunoreactive cells after double staining (data not shown). Recent studies on the prommer region of the DBH gene mapped the loeation of DNA sequences neeessary for the uanseriptional regulation of the DBH gene.l' This information appears relevant to produee engineered dopaminergic sympathetic neurones. These cells may be used for brain grafting in the ueatment of neurodegenerative diseases eharacterized by seleetive impairment of the dopaminergie system, sueh as Parkinson's disease.
Conclusions
This repon shows that EGF can be used to sclcetively induce the proliferation of multipotent progenitor eells from the human embryonie sympathetie chain. These cells can differentiate into NGF-responding neuronal eells. The reported method may be used to obtain a large number of eateeholaminergie human cells in order to better define the effeets of genetie and epigenetic influenees on the SA eell fate definition.
